ST段抬高型急性心肌梗死患者急诊经皮冠状动脉介入治疗中无复流现象的处理  

Management of no-reflow in emergency percutaneous coronary intervention for ST elevation myocardial infarction

作　　者：邹琼辉[1] 马伟东[1] 新怡康[1] 

机构地区：[1]广东省惠州市第一人民医院心内科,516001

出　　处：《中国实用医药》2012年第17期47-48,共2页China Practical Medicine

摘　　要：目的探讨ST段抬高型急性心肌梗死(STEMI)患者急诊经皮冠状动脉介入治疗(PCI)中无复流现象发生的原因及处理方法。方法回顾性分析18例STEMI患者急诊PCI治疗中无复流现象的发生情况。结果 18例无复流患者给予盐酸地尔硫萆、腺苷、溶栓剂等药物治疗和主动脉内反搏泵(IABP)治疗。18例患者中,术中及住院期间共死亡2例,病死率为11.1%。结论无复流现象是STE-MI患者PCI治疗中常见的合并症之一,有较高的病死率;药物和IABP的综合治疗对无复流患者有一定的疗效。Objective To explore the causeand management of no-reflow in emergency percutaneous coronary intervention（PCI） for ST elevation myocadial infarction （STEMI）. Methods We analyzed retrospec- tively 220 cases with STEM1 who were given emergency PCI from January 2009 to December 2006. Results No- reflow wag found in 18 of the 220 patients with STEMI during PCI, with an incidence of 8.2% ;All no-reflow pa- tients were given drug treatment（ with intraeoronary herbesser, adenosyl and thrombolytics ）and intraaortie bal- loon pumping（IABP）. 2 out of the 18 patients died during the operations and hospital stays,with a death rate of 11.1%. Conclusion No-reflow is a common complication with a high death rate in PCI for STEMI. The loca- tion of IRA and the time from onset to reperfusion are predictors of no-fellow. Combined pharnmeological approa- ches,including IABP, can improve IRA anterograde flow.

关 键 词：心肌梗死 经皮冠状动脉介入治疗 无复流现象 

分 类 号：R542.22[医药卫生—心血管疾病]